Parameters of coagulation oriented DIC treatment

Parameters of coagulation oriented DIC treatment - Parameters of coagulation oriented DIC treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016940

Enrollment

200

Registered

2015-03-27

Start date

2015-03-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory DIC

Interventions

Standard unticoagulant DIC treatment directed by JAAM DIC Score Standard unticoagulant DIC treatment directed by ATIII activity and TAT level

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Systemic Inflammatory Response Syndrome

Exclusion criteria

Exclusion criteria: hemorrhagic disease, malignancy

Design outcomes

Primary

Measure	Time frame
Patient Outcome, DIC free days	—

Secondary

Measure	Time frame
Use of drug for DIC treatment	—

Countries

Japan

Contacts

Public ContactJun Oda

Tokyo Medical University Emergency and CCM

junoda@v001.vaio.ne.jp+81-3-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026